HME Products

FRESNO, California—Sunrise Medical announced the launch of the new LECKEY MyWay+ Gait Trainer. The MyWay+ aims to open a world of independence and exploration for children. The minimalist, open-frame design supports children in an upright position, improving stepping and maximizing opportunities for exploration, interaction and participation.

DENVER, Colo.—OnTerra Systems, the developers of RouteSavvy route planning software, has introduced a new route optimization software engine and automated, multi-vehicle optimization in RouteSavvy route optimization software. This new release is a beta version of multi-vehicle optimization for customers & prospects to test drive & provide feedback to the OnTerra team.

FRESNO, California—Sunrise Medical has announced the launch of the new LECKEY MyWay+ Gait Trainer. The MyWay+ has a minimalist, open-frame design that supports children in an upright position, improving stepping and maximizing opportunities for exploration, interaction, and participation.

MINNEAPOLIS—Best Buy announced it will begin selling continuous glucose monitors (CGMs) via prescription and deliver them to homes. 

WASHINGTON—The Food and Drug Administration (FDA) isn’t satisfied with the recall of CPAP and respiratory devices from Philips Respironics and has urged the company to conduct more testing.

DUBLIN, Ohio—Cardinal Health (NYSE: CAH) announced the U.S. launch of its Kangaroo OMNI Enteral Feeding Pump, designed to help provide enteral feeding patients with more options to meet their personalized needs throughout their enteral feeding journey.

Pride Mobility announced the last of its new product releases for the summer, the PX4 mobility scooter, which offers a 500-pound weight capacity and a top speed of up to 9.3 mph. The PX4 also has 23.4-mile battery range, which Pride said makes it a good option for those seeking outdoor adventure.

WATERLOO, Iowa—The National Coalition for Assistive and Rehab Technology (NCART) and U.S. Rehab/VGM have joined forces to launch a comprehensive survey of the complex rehab technology (CRT) industry through the University of Northern Iowa’s Strategic Marketing Services program.

Pride Mobility introduced a new mobility scooter to its Baja Mobility line with the Baja Raptor 2 4-Wheel. 

"For speed, style and a suite of high-performance features, it’s Baja or bust," said Pride. 

The scooter features:

Pride Mobility announced the new Pursuit 2 mobility scooter on Monday, Aug. 7.

According to Pride, the Pursuit 2 is "built to handle adventures and outdoor terrain."

The mobility scooter has a cruising speed of 9.3 mph, a per-charge range of up to 40 miles and pneumatic tires.

ROCHESTER, New York—The National Coalition for Assistive & Rehab Technology (NCART), the nonprofit national association advocating for individuals needing complex rehab equipment, has contacted state Medicaid agencies to request increases to reimbursement rates for complex rehab technology (CRT).

AMSTERDAM—Philips Respironics has released updated results of testing on its recalled PAP and ventilation devices to the Food and Drug Administration, saying that the assessments available show patients exposed to chemicals and particulates by using them were unlikely to have appreciable harm to their health. 

NASHVILLE, Tennesse—National Seating & Mobility (NSM), a provider of comprehensive mobility solutions, announced Tony Ueber has been named as the company’s chief executive officer (CEO). He replaces Bill Mixon, who is joining the company’s Board of Directors.

GF Health Products, Inc. (Graham-Field) announced an expansion of its offering of Sub-Acute Care and Extended Care Beds. Manufactured in the United States at the Basic American Bed facility in Fond-du-Lac, Wisconsin, the new beds take advantage of Graham-Field’s manufacturing resources to include computer-controlled laser welding, robotic assembly and an upgraded automated coating line.

IRVINE, California—Masimo announced that Masimo Opioid Halo, an opioid overdose prevention and alert system, has been granted a De Novo by the FDA, making it the first and only FDA-cleared monitoring solution for detecting opioid-induced respiratory depression, the leading cause of death from opioid overdose. With the De Novo, Masimo also becomes the first winner of an FDA Opioid Innovation Challenge to have an authorized solution designed to help solve the U.S. opioid crisis.